Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Galvez-Cancino

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Reviews. Immunology|March 30, 2026
NK cell mechanosensing through CD16aMaria Armero, Felipe Galvez-Cancino
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Analysis of Tissue-Resident Immune Cells from Mouse Skin and Lungs by Flow CytometryFelipe Galvez-Cancino, Ernesto Lopez, Alvaro Lladser
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Engineering and improving anti-CTLA-4 checkpoint inhibitorsFelipe Galvez-Cancino, Eileen E Parkes, David R Withers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2025
Facts and hopes in harnessing macrophage-mediated antibody-dependent cellular phagocytosis for cancer immunotherapyMaria Armero, Manuel Smolkin, Mario Garcia-Dominguez, et al.
Annual Review of Medicine|November 13, 2025
Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody DevelopmentMariela Navarrete, Cristobal Costoya, Felipe Galvez-Cancino, et al.
Seminars in Cancer Biology|April 10, 2023
The tumour ecology of quiescence: Niches across scales of complexitySimon P Castillo, Felipe Galvez-Cancino, Jiali Liu, et al.
Cancer Discovery|September 4, 2025
The Dark Side of NK Cells in Cancer ImmunotherapyFelipe Galvez-Cancino, Maria Armero, David R Withers, et al.
Nature Reviews. Cancer|December 7, 2023
Fcγ receptors and immunomodulatory antibodies in cancerFelipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya, et al.
Journal for Immunotherapy of Cancer|July 3, 2023
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignanciesErnesto Lopez, Rajesh Karattil, Francesco Nannini, et al.
Journal for Immunotherapy of Cancer|October 29, 2025
Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinicIñaki Eguren-Santamaria, Ignacio Melero, Inmaculada Rodríguez, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Reviews. Immunology|March 30, 2026
NK cell mechanosensing through CD16aMaria Armero, Felipe Galvez-Cancino
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Analysis of Tissue-Resident Immune Cells from Mouse Skin and Lungs by Flow CytometryFelipe Galvez-Cancino, Ernesto Lopez, Alvaro Lladser
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Engineering and improving anti-CTLA-4 checkpoint inhibitorsFelipe Galvez-Cancino, Eileen E Parkes, David R Withers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2025
Facts and hopes in harnessing macrophage-mediated antibody-dependent cellular phagocytosis for cancer immunotherapyMaria Armero, Manuel Smolkin, Mario Garcia-Dominguez, et al.
Annual Review of Medicine|November 13, 2025
Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody DevelopmentMariela Navarrete, Cristobal Costoya, Felipe Galvez-Cancino, et al.
Seminars in Cancer Biology|April 10, 2023
The tumour ecology of quiescence: Niches across scales of complexitySimon P Castillo, Felipe Galvez-Cancino, Jiali Liu, et al.
Cancer Discovery|September 4, 2025
The Dark Side of NK Cells in Cancer ImmunotherapyFelipe Galvez-Cancino, Maria Armero, David R Withers, et al.
Nature Reviews. Cancer|December 7, 2023
Fcγ receptors and immunomodulatory antibodies in cancerFelipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya, et al.
Journal for Immunotherapy of Cancer|July 3, 2023
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignanciesErnesto Lopez, Rajesh Karattil, Francesco Nannini, et al.
Journal for Immunotherapy of Cancer|October 29, 2025
Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinicIñaki Eguren-Santamaria, Ignacio Melero, Inmaculada Rodríguez, et al.
Pageof 2